Express News | Zhejiang Anglikang Pharmaceutical: Subsidiary has obtained the approval number for the veterinary drug Furosemide tablets.

BreakingsMar 4 17:04

Zhejiang Anglikang Pharmaceutical (002940.SZ): Accumulated repurchase of 1.4% of shares.

On March 3, Gelonghui reported that Zhejiang Anglikang Pharmaceutical (002940.SZ) announced that as of February 28, 2025, the company had repurchased a total of 2,820,000 shares through a dedicated repurchase securities Account using centralized bidding Trade, accounting for approximately 1.40% of the company's total share capital, with a maximum Fill Price of 14.87 yuan per share, a minimum Fill Price of 13.38 yuan per share, and a total transaction amount of 40,395,922.86 yuan (excluding transaction fees). This repurchase complies with the company's repurchase plan requirements.

Gelonghui FinanceMar 3 16:55

AngliKang Pharma Gets Registration Certificate for L-Carnitine Injection

MT NewswiresFeb 26 14:34

Express News | Zhejiang Anglikang Pharmaceutical: Obtained the pharmaceutical registration certificate for L-Carnitine injection.

BreakingsFeb 25 17:05

Express News | Zhejiang Anglikang Pharmaceutical: Application for clinical trial of injectable ALK-N001 has been accepted.

BreakingsFeb 18 16:53

Zhejiang AngLiKang Pharmaceutical Subsidiary Receives Approval for Finasteride API

MT NewswiresFeb 14 14:52